본문으로 건너뛰기
← 뒤로

Conversion Surgery after Chemotherapy in a Stage IV V600E-Mutated Laterally Spreading Tumor With Neuroendocrine Component.

DEN open 2026 Vol.6(1) p. e70283

Kawamura R, Toyoshima N, Sekiguchi M, Takamaru H, Yamada M, Kobayashi N, Hirano H, Takamizawa Y, Hashimoto T, Saito Y

📝 환자 설명용 한 줄

We report a rare case of a V600E-mutated laterally spreading tumor, granular type (LST-G), with a neuroendocrine carcinoma (NEC) component in a patient with stage IV colorectal cancer.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Kawamura R, Toyoshima N, et al. (2026). Conversion Surgery after Chemotherapy in a Stage IV V600E-Mutated Laterally Spreading Tumor With Neuroendocrine Component.. DEN open, 6(1), e70283. https://doi.org/10.1002/deo2.70283
MLA Kawamura R, et al.. "Conversion Surgery after Chemotherapy in a Stage IV V600E-Mutated Laterally Spreading Tumor With Neuroendocrine Component.." DEN open, vol. 6, no. 1, 2026, pp. e70283.
PMID 41647691
DOI 10.1002/deo2.70283

Abstract

We report a rare case of a V600E-mutated laterally spreading tumor, granular type (LST-G), with a neuroendocrine carcinoma (NEC) component in a patient with stage IV colorectal cancer. The patient presented with multiple lymph nodes and liver metastases. Following systemic chemotherapy, significant regression of both the primary lesion and metastases was achieved, enabling successful conversion surgery. Postoperative pathological analysis post-surgery revealed only well-differentiated tubular adenocarcinoma, with complete disappearance of the NEC component. Molecular testing confirmed the persistence of the V600E mutation. The patient remains recurrence-free two years after surgery. This case highlights the potential for conversion surgery in stage IV -mutated colorectal cancer with NEC.